Press Releases

2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

2008 Press Releases

Listed below are all of the QLT press releases available for the year you have selected.

December 16	QLT Announces Interim Results of RADICAL Study Evaluating Visudyne® Combination Therapy	PDF version
December 05	QLT Announces Commencement of Tender Offer	PDF version
December 01	QLT To Repurchase Up to US$50 Million of Common Shares	PDF version
October 28	QLT Announces Encouraging Phase II Data From Core Study of Punctal Plug Drug Delivery System	PDF version
October 28	QLT Announces Third Quarter Results for 2008	PDF version
October 20	QLT Announces Third Quarter 2008 Visudyne® Sales	PDF version
October 09	QLT Announces the Initiation of a Phase I Trial of its Synthetic Retinoid Product	PDF version
September 15	QLT Announces Completion of the Redemption of 3% Convertible Senior Notes Due 2023	PDF version
September 02	QLT Completes CDN$65.5 Million Real Estate Transaction	PDF version
August 26	QLT Announces Agreement to Exclusively License the Atrigel® Technology to Reckitt Benckiser Pharmaceuticals Inc.	PDF version
August 11	QLT Announces Redemption of 3% Convertible Senior Notes Due 2023	PDF version
August 08	QLT Announces Removal of Conditions on CDN$65.5 Million Real Estate Transaction	PDF version
July 29	QLT Announces Second Quarter Results for 2008	PDF version
July 17	QLT Announces Second Quarter 2008 Visudyne® Sales	PDF version
July 14	QLT Completes Divestment of Aczone® to Allergan for USD$150 Million	PDF version
June 09	QLT Announces Agreement to Sell Aczone® to Allergan for Approximately US$150 Million	PDF version
June 06	QLT Announces Positive Health Canada Decision on Aczone®	PDF version
May 15	QLT Inc. Announces Agreement for Sale of Real Estate	PDF version
May 12	QLT Reports Initial Proof-of-Concept Data for Punctal Plug Delivery Technology	PDF version
May 05	QLT Completes Enrollment in the RADICAL Study	PDF version
April 25	QLT Announces First Quarter Results for 2008	PDF version
April 21	QLT Announces First Quarter 2008 Visudyne® Sales	PDF version
March 31	QLT Initiates Phase II Study of Punctal Plug Drug Delivery System for Glaucoma & Ocular Hypertension	PDF version
March 28	Positive Results from Visudyne® Combination Therapy Study Reported at Annual Macula Society Conference	PDF version
March 17	QLT Announces Positive FDA Action on Aczone™	PDF version
February 21	QLT Announces 2007 Results	PDF version
January 18	QLT Reduces Workforce as First Step in its Strategic Restructure	PDF version
January 17	QLT Announces Visudyne® Sales for Fourth Quarter and Fiscal Year 2007	PDF version
January 16	QLT Inc. Announces Initial Steps in Strategic Restructuring	PDF version

Visudyne® is a registered trademark of Novartis AG

Vancouver Web Design by Graphically Speaking